IMR Press / CEOG / Volume 21 / Issue 2 / pii/1994017

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Is there a link between beta-endorphin and diabetes in pregnancy?

Show Less
1 Department of Obstetrics and Gynecology School of Medicine, Belgrade (Yugoslavia)
2 Institute of Anatomy, School of Medicine Belgrade (Yugoslavia)
3 Serbian Academy of Sciences and Arts Belgrade, Yugoslavia
Clin. Exp. Obstet. Gynecol. 1994, 21(2), 91–93;
Published: 10 June 1994
Abstract

The possible influence of both beta-endorphin and insulin secretion on diabetes development in pregnant women was studied by means of radioimmunoassay technique (RIA-Nichols Institute). The study was carried out by determination of beta endorphins in peripheral blood samples of 28 pregnant women with gestational diabetes. They consisted of two subgroups: 14 women with insulin independence, and 14 with insulin-dependent disease. Beta endorphin increase was found in both groups, according to the progression of gestation, and the rise was significantly higher in the insulin-dependent group. At the same time, insulin application caused a marked growth of beta-endorphins in insulin-dependent group. Beta-endorphins, inhibiting insulin secretion, can influence gestational diabetes development.

Keywords
Beta-endorphins
Gestational diabetes
Share
Back to top